Latest TroVax Stories
Third Phase 3 Trial of Custirsen to Receive FDA Fast Track Designation BOTHELL, Wash.
ThermoDox Demonstrates Impressive Response Rate in Refractory Patients LAWRENCEVILLE, N.J., Feb.
WORCESTER, Mass. and TORONTO, Feb.
AUSTIN, Texas, Jan.
Latest Data from Large Subgroup of Patients Shows that the Combination of ThermoDox® and Optimized RFA Provides a Statistically Significant Survival Improvement of Over 50% LAWRENCEVILLE,
Younger patients with colorectal cancer that has spread to other parts of the body represent a high-risk group that is less likely to respond to treatment.
- To give a box on the ear to.